VentureBeat
VerifiedOnline/Digital
VentureBeat is an American technology website. Headquartered in San Francisco, it publishes news, analysis, long-form features, interviews, and videos. Source
Actions
Media Outlet details
| Scope | National |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
| Accepts contributed content | Yes |
Recent Articles
Search ArticlesOrthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program
Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass.--(BUSINESS WIRE)--April 17, 2026-- Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first-in-class drug against BK polyomavirus. BK virus infections are a major cause of complications in transplant patients, with no approved treatments.
AI lowered the cost of building software. Enterprise governance hasn’t caught up
Presented by Retool The logic used to be: buying software is cheaper, faster, and safer for most use cases. Building was reserved for companies with large engineering teams, deep pockets, and problems so specific that no vendor could address them. But now, the cost to code a piece of software has dropped to zero. Anyone can build their own software now, but enterprise and governance models have yet to catch up. Retool’s 2026 Build vs.
Opna Bio Announces Fast Track Designation Granted to OPN-6602 for the Treatment of Multiple Myeloma
OPN-6602 Currently Treating Patients in Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 15, 2026-- Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to OPN-6602, a dual EP300/CBP inhibitor, for the treatment of multiple myeloma (MM).
Capsule Security Exits Stealth With $7M to Stop AI Agents From Going Rogue at Runtime
Runtime visibility and real-time control stop malicious actions and tool abuse across agent platforms without proxies, gateways, or SDKs TEL AVIV, Israel--(BUSINESS WIRE)--April 15, 2026-- Capsule Security, a trust layer for agentic AI, today launched from stealth with a $7 million seed round led by Lama Partners alongside Forgepoint Capital International. Capsule secures the most unpredictable component in the AI stack at runtime.
Horizon Quantum and AQT to Advance Real-World Quantum Applications with Strategic Hardware–Software Collaboration
By integrating Horizon’s software infrastructure with AQT’s trapped-ion quantum computing systems, this collaboration helps accelerate progress towards real-world quantum applications. SINGAPORE & INNSBRUCK, Austria--(BUSINESS WIRE)--April 15, 2026-- Horizon Quantum Computing Pte. Ltd., the wholly-owned subsidiary of Horizon Quantum Holdings Ltd.
CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions’ Expanded Credit Facility and Syndicate to Support Acquisition of Acterys
TORONTO--(BUSINESS WIRE)--April 15, 2026-- CIBC Innovation Banking announced today its role as Lead Arranger and Administrative Agent in an expanded credit facility for Vena Solutions (Vena), a top-tier AI-powered Microsoft-native Financial Planning and Analysis (FP&A) platform that connects data, people and agents to help customers plan better and achieve more.
Prefix Secures $7.5M to Scale its Facility Management Solution Bringing 3x Efficiency Gains to Retail and Restaurant Operators
AI platform delivers up to 15%+ cost savings by bridging the gap between large multi-site brands and local technicians NEW YORK--(BUSINESS WIRE)--April 14, 2026-- Prefix, a facility management platform for multi-site restaurant and retail operators, today announced it has raised a $7.5 million seed round. The funding was co-led by Collide Capital and Slow Ventures, with participation from Connexa Capital, Kyle Archer of Elevated Inc, and existing investors I2BF, and Bienville Capital.
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform
Proceeds will help enhance workflows and expand single-cell functional assay portfolio Brad Crutchfield joins as advisor to support early access growth and upcoming global launch CAMBRIDGE, England--(BUSINESS WIRE)--April 14, 2026-- Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced the closing of a $27 million financing raised from existing investors.
Stephens Group Forms Aptus Aero, Appoints Dale Gabel as CEO, and Acquires Atlas Aerospace
LITTLE ROCK, Ark.--(BUSINESS WIRE)--April 14, 2026-- The Stephens Group, LLC (“Stephens Group”) is pleased to announce the formation of Aptus Aero, LLC (“Aptus Aero”), a provider of maintenance, repair, and overhaul (“MRO”) services for the aviation industry. Aptus Aero will serve as a new platform for Stephens Group with a focus on acquiring and growing market leading component MRO businesses.
Credo Agrees to Acquire DustPhotonics, Accelerating Expansion into Silicon Photonics and Next Generation Optical Connectivity
Acquisition will bring industry-leading Silicon Photonics PIC technology in-house, expanding Credo's addressable market and deepening its optical interconnect portfolio across 800G, 1.6T, and 3.2T NPO and CPO SAN JOSE, Calif.--(BUSINESS WIRE)--April 13, 2026-- Credo Technology Group Holding Ltd (Credo) (NASDAQ: CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved reliability and energy efficiency for the next generation of AI-driven applications,...